|
TMF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.54599999999872E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.92360000000181E-05 |
| Normal-vs-Stage2 |
7.709900E-02 |
| Normal-vs-Stage3 |
8.124300E-03 |
| Normal-vs-Stage4 |
1.668300E-02 |
| Stage1-vs-Stage2 |
8.930600E-01 |
| Stage1-vs-Stage3 |
8.566000E-01 |
| Stage1-vs-Stage4 |
5.781000E-01 |
| Stage2-vs-Stage3 |
8.142800E-01 |
| Stage2-vs-Stage4 |
5.889600E-01 |
| Stage3-vs-Stage4 |
6.713600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.14429999999544E-05 |
| Normal-vs-AfricanAmerican |
2.276700E-03 |
| Normal-vs-Asian |
1.323570E-03 |
| Caucasian-vs-AfricanAmerican |
8.303200E-01 |
| Caucasian-vs-Asian |
5.226800E-01 |
| AfricanAmerican-vs-Asian |
4.560000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.49749999967375E-08 |
| Normal-vs-Female |
8.825400E-01 |
| Male-vs-Female |
1.213260E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.417000E-03 |
| Normal-vs-Extreme_Weight |
5.70949999945114E-07 |
| Normal-vs-Obese |
2.014200E-02 |
| Normal-vs-Extreme_Obese |
1.577830E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.062800E-01 |
| Normal_Weight-vs-Obese |
4.370800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.112000E-01 |
| Extreme_Weight-vs-Obese |
4.517700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.313200E-01 |
| Obese-vs-Extreme_Obese |
2.837200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.182000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.664400E-03 |
| Normal-vs-Age(61-80Yrs) |
4.40270000012788E-07 |
| Normal-vs-Age(81-100Yrs) |
3.60890000000724E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.597400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.180400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.142200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.963800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.925600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.489000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.88690000000014E-05 |
| Normal-VS-Type2 PRCC |
7.07680000155975E-08 |
| Normal-VS-KIRP CIMP |
4.986400E-01 |
| Normal-VS-Unclassified PRCC |
2.435400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.277960E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.760280E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.542400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.379880E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.321760E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.224600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62249999990927E-07 |
| Normal-vs-N1 |
3.812200E-02 |
| Normal-vs-N2 |
4.086400E-01 |
| N0-vs-N1 |
1.144020E-01 |
| N0-vs-N2 |
6.656400E-01 |
| N1-vs-N2 |
7.836400E-01 |
|
|
